Investigating the possibility of synthesizing biscoumarin derivatives using 4-hydroxycoumarin and aromatic aldehydes in the presence of various catalysts such as thiourea, urea, silica gel enriched with sulfuric acid

Number of pages: 74 File Format: word File Code: 32089
Year: Not Specified University Degree: Master's degree Category: Paramedical
  • Part of the Content
  • Contents & Resources
  • Summary of Investigating the possibility of synthesizing biscoumarin derivatives using 4-hydroxycoumarin and aromatic aldehydes in the presence of various catalysts such as thiourea, urea, silica gel enriched with sulfuric acid

    Persian summary:

    Coumarin derivatives are of great interest due to their biological importance and medicinal activities. A number of coumarin derivatives, especially biscoumarins, have been known for their numerous and prominent features such as anti-blood clots, anti

    and KSF enriched with HCl was studied and the yield of the reaction was checked using the above reagents.

    In another synthesis, the following tetrakis product was prepared using 4 moles of 4-hydroxycoumarin and 1 mole of terephthalaldehyde.

    Then the synthesis of the above products was confirmed by IR, 1H NMR, 13C NMR and Mass tests.

    Key words: biscoumarin, urea, thiourea, aldehyde, clinical resistance

    Chapter one:

    General

    Subject plan:

    Synthesis of biscoumarin derivatives using different aldehydes in the presence of various catalysts and investigation of their biological effects

    1-2) Statement of the problem:

    In this research, while investigating the possibility of synthesizing various biscoumarins under different catalytic and solvent conditions, their biological properties on Gram-positive and Gram-negative bacteria were investigated. 

    1-3) Necessity of conducting research:

    Bacterial diseases such as Staphylococcus aureus, hemolytic streptococcus, gonorrhea, syphilis, gangrene and bacterial endocarditis will have terrible effects and consequences in infected people. These people suffer from severe headache, fever, paralysis and destruction of internal organs and in some cases they die. Before the discovery and use of antibiotics, doctors did not have any tools to fight these pathogens. Penicillin is the most widely used and widely known antibiotic, which easily saved many lives during World War II. The development of drugs that prevent or treat microbial infections is one of the main advances in the field of improving the quality and quantity of life in recent years. Antimicrobial drugs are one of the most widely used types of drugs, which can be life-saving if used correctly, and at the same time, their incorrect and inappropriate use increases the cost, many side effects and drug interactions, drug resistance, and the devaluing of these valuable drugs. "Drug resistance" has attracted the attention of scientists and scientific circles for several years. A few years ago, a scientist predicted that despite the very high rate of drug resistance, all antibiotics will be ineffective in a few decades, and this means that mankind will return to the era before the discovery of penicillin! The evidence indicates that this scientist's prediction is slowly happening because new reports of drug resistance to antibiotics are being published from time to time. Despite the fact that antibiotics have saved the lives of countless humans and animals so far; But many wonderful drugs have reached the end of the line, because pathogenic bacteria have learned to resist them. In this regard, the interest and efforts to discover new antibacterial agents, whether natural, semi-synthetic or even fully synthetic, have increased. According to the above, the importance and need to synthesize new compounds that have appropriate antibiotic properties is an undeniable necessity. In addition to their traditional use, coumarin derivatives are used as anticoagulants (anti-vitamin K activity) (1). It has antibiotic activities (2) (it is present in the structure of antibiotics such as Novobiocin and its analogues) and has been used as antitumor drugs (geiparvarin) (3) (4). Coumarin derivatives have various physiological activities such as temperature reduction properties.They are antibacterial (5) and among their other properties, we can mention their effect against Leishmania, which is one of the initiators (6). A number of coumarin derivatives, especially biscoumarins, are known for their numerous and prominent properties such as anti-AIDS (7), anti-cancer (8), antimicrobial activity (9) and antioxidant (10), urease inhibition (11), enzyme inhibition activities (12-14) and cytotoxicity (5). In this research, we also decided to conduct a new method for the synthesis of biscoumarin derivatives and investigate the antimicrobial properties of these compounds. This study investigated the possibility of synthesizing biscoumarin derivatives using 4-hydroxycoumarin and aromatic aldehydes in the presence of various catalysts such as thiourea, urea, and silica gel enriched with sulfuric acid. . Meanwhile, our next goal is to investigate the antimicrobial properties of the above-mentioned compounds against some gram-positive and negative bacteria, which are reported in this thesis.

    1-5) Questions:

    By conducting this research, these questions will be answered:

    1) The best yield of the product is obtained during the reaction with which catalyst?

    2) Which catalyst has the shortest reaction time?

    3) Which aldehydes give the best product formation efficiency? Aldehydes with electron-killing or electron-donating groups?

    4) Examining the effect of different compounds on Gram-positive bacteria using the Agar-Well dilution Method

    5) Examining the effect of different compounds on Gram-negative bacteria using the Agar-Well dilution Method

    1-6) Definition of words:

    1-6-1 (One-pot reactions):

    A one-step synthesis is a strategy to improve the efficiency of a chemical reaction that involves reactants reacting in a reactor. This issue has been of great interest to chemists because by this means the long process of isolating and purifying compounds is limited. The intermediates are avoided and the waste of resources and time is eliminated, while the chemical yield is increased. The synthesis of one step can even be used for the production of complex drugs with several spatial centers (such as the synthesis of oseltamivir, which is an antiviral drug) (15) and have important commercial achievements. In a one-step synthesis, successive reactants are added to the reactor one at a time (this method is also called telescopic synthesis). react to form a new product that contains parts of all the reactants. The result of the reaction clearly depends on the reaction conditions: solvent, temperature, catalyst, type of raw materials, concentration and functional groups. Such considerations are of particular importance in relation to the design and discovery of new MCRs.

    Conventional multicomponent reactions in organic reactions have several advantages. They are useful in the process of drug making and in the pharmaceutical industry and related matters. They are one-pot reactions that often give products in good yields. The first multicomponent reaction was performed in 1838 by Laurent and Gerhart. Multicomponent reactions officially started in 1850, when Strecker was able to prepare ?-amino acids by using ammonia, carbonyl compounds and hydrogen cyanide. The preparation of heterocyclic compounds by multicomponent reactions started in the early 1880s (16).

  • Contents & References of Investigating the possibility of synthesizing biscoumarin derivatives using 4-hydroxycoumarin and aromatic aldehydes in the presence of various catalysts such as thiourea, urea, silica gel enriched with sulfuric acid

    List:

    None.  

    Source:

     

    Shapiro, S., Sherwin, B., 1943, The use of dicumarol (3, 3'-methylenebis (4-hydroxycoumarin) in embolization, Report of five cases. N. Y. State J. Med, vol. 43, p.45–52.

    Marcu, M G., Schulte, W T., Neckers, L., 2000, Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins, J Natl Cancer Inst, vol.92, p.242-248.

    Raev, L., Voinov, E., Ivanov, I., Popov, D., 1990, Antitumor activity of some coumarin derivatives, Pharmazie, vol.45, p.696.

    Tripathi, A., Mukherjee, D., Koul, S., Taneja, S C., 2009, Synthesis and cytotoxicity of novel benzopyran derivatives, IJC-B, vol.50, p.1619-1629.

    Chohan, Z., Shaikh, A., Rauf, A., Supuran, T., 2006, Antibacterial, antifungal and cytotoxic properties of 4-hydroxycoumarin, J. Enz. Med. Chem, vol. 21, p. 741-748. Gomes, C., Alegrio, V., deLima, L., Ara?jo, C., 2002. vol. 52, p.120-4.

    Nofal, M., Zahar, El., Abd El-Karim, S., 2000, Novel Coumarin Derivatives with Expected Biological Activity, Molecules, vol. 5, p.99-11

    Velasco-Vel?zquez, M., 2003, 4 Hydroxycoumarin disorganizes the actin cytoskeleton in B16–F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility, Cancer Lett, vol.198, p.179–186.

    Chih-Chia, C., Ling-Yih H., Hou-Jen T., Chen-Wen Y., Tsu-Chung C., 2008, Synthesis and Antimicrobial Evaluation of Coumarin Derivatives, Journal of Chung Cheng Institute of Technology, vol.37, p.183-189

    Kostova, I., Raleva, S., Genova, P., Argirova, R., 2006, Structure-Activity Relationships of Synthetic Coumarins. as HIV-1 Inhibitors, Bioinorg Chem Appl, vol. 14, p. 1-9.

    Khan, K., Iqbal, S., 2004, Biscoumarin: new class of urease inhibitors, economic synthesis and activity, Bioorg. Med. Chem, vol. 12, p.1963-1968.

    Zhao, H., Neamati, N., Hong, H., Mazumder, A., Wang, S., Sunder, S., Miline, G. W. A., Pommier, Y., 1997, Coumarin-Based Inhibitors of HIV Integrase, J. Med. Chem, vol. 40, p.42-249.

    Mao, P., Mouscadet, F., Leh, L., Auclair, C., Hsu, Y., 2002, Chemical Modification of Coumarin Dimer and HIV-1 Integrase Inhibitory Activity, Chem. Pharm. Bull, vol. 50, p. 1634-1637.

    Su, X., Mouscadet, F., Chiang, C., Tsai, J., Hsu, Y., 2006, HIV-1 Integrase Inhibition of Biscoumarin Analogues, Chem Pharm Bull, vol.54, p. 682-686.

    Ishikawa, H., Suzuki, T., Hayashi, Y., 2009, High-yielding synthesis of the anti-influenza neuramidase inhibitor (-)-oseltamivir by three "one-pot" operations, Angewandte Chemie vol.48, p. 1304–1307.

    Biginelli, P., 1893, Biginelli Reaction Gazz. Chim. Ital, vol.23, p.360-355.

    Jieping, Z., Hugues B., 2005, Multicomponent Reactions. Wiley-VCH, vol.17, p.468-475

    D?mling, I., 2000, Multicomponent Reactions with Isocyanides, Chem. Int. E, vol. 39, p. 168-176.

    A. D?mling., 2004, Multicomponent Reactions - Superior Chemistry Technology for the New Millennium, Org. Chem. Highlights, vol.5, p.256-264.

    Calderon, C., Sabundayo, B., 2007, Antimicrobial Classifications: Drugs for Bugs, CRC Press. Taylor & Frances group, vol. 125, p. 978-985

    Foster, W., Raoult, A., 1974, Early descriptions of antibiosis, J R Coll Gen Pract, vol.24, p. 889–94.

    Landsberg, H., 1949, Prelude to the discovery of penicillin, Isis, vol.40, p. 225–227.

    Limbird, LE., 2004, The receptor concept: a continuing evolution, Mol. Interview, vol. 6, p.326–36.

    Bosch, F., Rosich, L., 2008, the contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize, Pharmacology, vol.82, p. 171-9.

    Available from:pubmedcentral.nih.gov /articlerender.fcgi?tool = pmcentrez & artid = 2790789, accessed 8/19/2014

    Landsberg, H., 1949, Prelude to the discovery of penicillin, Isis, vol.40, p. 225–227.

    Waksman, S., 1947, What Is an Antibiotic or an Antibiotic Substance? , Mycologia, vol. 39, p. 565–569.

    Limbird, L., 2004, The receptor concept: a continuing evolution, Mol. Interview, vol. 4, p. 326–36.

    Craig, C., Stitzel, R., 2003, Modern Pharmacology with Clinical Applications, 6th ed. Lippincott Williams, Wilkins, p. 510.

    John, L., Keith, P., 2005, the pharmacological basis of therapeutics, 10th Ed. New York: McGraw-Hill.

    Available from: www.cdc.gov/abcs/reports-findings/./antibiogram-method.pdf, accessed 8/19/2014.

    WHO., 2002, Use of antimicrobials outside human medicine and resultant antimicrobial resistance in humans, World Health Organization.

    Arias, A., Murray, B., 2009, Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge, N Engl J Med, vol.360, p. 43-439.

    D'Costa, V., King, C., Kalan, L., Morar, M., Sung, W., Schwartz, C., Froese, D., 2011, Antibiotic resistance is ancient, Nature, vol.477, p. 457–461.

    Donadio, S., Maffioli, S., Monciardini, P., Sosio, M., Jabes, D., 2010, Antibiotic discovery in the twenty-first century: Current trends and future perspectives, J Antibiot , vol.63, p. 423–430.

    Hawkey, P., Jones, A., 2009, The changing epidemiology of resistance, J. Antimicrob. Chemother, vol. 64, p. 3–10.

    Madigan, M., Martinko, M., Brock, D., 2005, Brock biology of microorganisms, 11th Ed, Upper Saddle River, NJ: Pearson Prentice Hall.

    Shih, YL., Rothfield, L., 2006, The bacterial cytoskeleton, Microbiol Mol Biol Rev. Vol. 70, No. 3, p. 729–54.

    Mehrabi, H., Abusaidi, H., 2010, Synthesis of Biscoumarin and 3,4-Dihydropyrano[c]chromene Derivatives Catalysed by Sodium Dodecyl Sulfate (SDS) in Neat Water, J Iran Chem Soc, vol.7, No.4, p.890-894.

    Jaiprakash, S., Nagnnath, K., Devanand, S., 2009, Water mediated efficient one-pot synthesis of bis-(4-hydroxycoumarin) methanes, Green Chemistry Letters and Reviews, vol.2, No.4, p.233-235.

    Li, W., Wang, Y., Wang, Z., Dai, L., Wang, Y., 2011, Novel SO3H-Functionalized Ionic Liquids Based on Benzimidazolium Cation: Efficient and Recyclable Catalysts for One-Pot Synthesis of Biscoumarin Derivatives, Catal Lett, vol.141, p.1651-1658.

    Tabatabaeian, K., Heidari, H., Khorshidi, A., Mamaghani, M., Mahmoodi, N., 2012, Synthesis of biscoumarin derivatives by the reaction of aldehydes and 4-hydroxycoumarin using ruthenium (III) chloride hydrate as a versatile homogeneous catalyst, J. Serb. Chem. Soc, vol.77, No.4, p.407–413.

    Gasparova, R., Kotlebova, K., Lacova, M., 2009, Reaction of 4-hydroxycoumarin with heterocyclic aldehydes, Nova Biotechnologica, vol.9, No.3, p. 349.

    Manolov, I., Maichle-Moessmer, C., 2012, Synthesis and Structure of 3, 3¢-[(4-Benzyloxyphenyl) methylene] bis-(4- hydroxy-2H-chromen-2-one), X-ray Structure Analysis Online, Vol. 28, p.7-8.

    Jianfeng, Z., Guixia, G., Litao, A., Xiaojun, S., Fengxia, X., 2009, Synthesis of 3,3-Arylidene Bis(4-hydroxycoumarin) Catalyzed by Sulfamic Acid in Aqueous Media under Microwave Irradiation, Chin J Org Chem, vol.12, p.1988-1991.

    Khurana, M., Kumar, S., 2009, Tetrabutylammonium bromide (TBAB): a neutral and efficient catalyst for the synthesis of biscoumarin and 3,4-dihydropyrano[c]chromene derivatives in water and solvent-free conditions, Tetrahedron Lett, vol.50, p.4125-4127.

    Kidwai, M., 2007, Molecular iodine: A versatile catalyst for the synthesis of bis(4-hydroxycoumarin) methanes in water, vol.268, No.2, p. 76-81.

    Khurana, J.M., Kumar, S., 2010, Ionic liquid: an efficient and recyclable medium for the synthesis of octahydroquinazolinone and biscoumarin derivatives, Monatsh Chem, vol.141, p.561-564.

Investigating the possibility of synthesizing biscoumarin derivatives using 4-hydroxycoumarin and aromatic aldehydes in the presence of various catalysts such as thiourea, urea, silica gel enriched with sulfuric acid